Health Care Complaints Commission v Haydon
[2021] NSWCATOD 63
At a glance
Source factsCourt
NCAT Occupational
Decision date
2021-03-05
Before
Associate Prof P
Source
Original judgment source is linked above.
Judgment (16 paragraphs)
REASONS FOR DECISION
- The reasons for the complaint brought by the Applicant appear from the amended Complaint lodged with the Tribunal under Case No. 2020/00212429 on 2 March 2021.
The Complaint The Health Care Complaints Commission of Level 13, 323 Castlereagh Street, Sydney NSW, having consulted with the Pharmacy Council of New South Wales in accordance with sections 39(2) and 90B(3) of the Health Care Complaints Act 1993 and section 145A of the Health Practitioner Regulation National Law (NSW) ("the National Law") HEREBY COMPLAINS THAT Ms Kristen Haydon ("the practitioner") of… New Lambton, New South Wales 2305 being a pharmacist registered under the National Law, BACKGROUND TO ALL COMPLAINTS The practitioner was first registered to practise as a pharmacist on 1 May 2009. On 26 March 2013, the practitioner commenced employment as the pharmacist in charge at Erina Heights Chemist Outlet situated at 375 The Entrance Road, Erina Heights in the State of New South Wales ("the Pharmacy"). From 1 January 2017 to 3 September 2018, the practitioner was one of two pharmacists in charge at the Pharmacy working ordinarily 5 days per week as the sole pharmacist working. On 10 September 2018, the Pharmaceutical Regulatory Unit ("PRU") inspected the Pharmacy. On 13 September 2018, the PRU submitted a complaint to the Pharmacy Council of New South Wales. COMPLAINT ONE is guilty of unsatisfactory professional conduct under section 139B(1)(a) and (I) of the National Law in that the practitioner has: i. engaged in conduct that demonstrates the knowledge, skill or judgment possessed, or care exercised, by the practitioner in the practice of pharmacy is significantly below the standard reasonably expected of a practitioner of an equivalent level of training or experience; and/or ii. engaged in improper or unethical conduct relating to the practice or purported practice of pharmacy. PARTICULARS OF COMPLAINT ONE 1. Between 1 January 2017 and 3 September 2018, the practitioner was one of two pharmacists in charge at the Pharmacy, during which time large numbers of drugs of addiction were unaccounted for and were possibly lost, stolen or diverted including as follows: a) Mayne Pharma oxycodone 5mg (20 tablets pack) - 5,000 tablets; b) Kalma 0.5mg (alprazolam) (10 tablets pack) - 100 tablets; c) Kalma 0.5mg (alprazolam) (50 tablets pack) - 100 tablets; d) Kalma 0.25mg (alprazolam) (50 tablets pack) - 250 tablets; e) Kalma 1mg (alprazolam) (50 tablets pack) - 300 tablets; f) Kalma 2mg (alprazolam) (50 tablets pack) - 250 tablets; g) Alprax 2mg (alprazolam) (50 tablets pack) - 50 tablets; h) Oxycodone Sandoz 10mg (28 tablets pack) - 1,036 tablets; i) Oxycodone Sandoz 20mg (28 tablets pack) - 140 tablets; and j) Endone 5mg (oxycodone) (20 tablets pack) - 1,700 tablets. 2. Between 1 January 2017 and 3 September 2018, on days that the practitioner was working at the Pharmacy, the practitioner failed to enter drugs of addiction into the dangerous drugs register contrary to Clause 56 of the Poisons and Therapeutic Goods Regulation 2008 (NSW) ("PTGR") including as follows: a) Mayne Pharma oxycodone 5mg (20 tablets pack) - 5,000 tablets; b) Kalma 0.5mg (alprazolam) (10 tablets pack) - 100 tablets; c) Kalma 0.5mg (alprazolam) (50 tablets pack) - 100 tablets; d) Kalma 0.25mg (alprazolam) (50 tablets pack) - 250 tablets; e) Kalma 1mg (alprazolam) (50 tablets pack) - 300 tablets; f) Kalma 2mg (alprazolam) (50 tablets pack) - 250 tablets; g) Alprax 2mg (alprazolam) (50 tablets pack) - 50 tablets; h) Oxycodone Sandoz 10mg (28 tablets pack) - 1,036 tablets; i) Oxycodone Sandoz 20mg (28 tablets pack) - 140 tablets; and j) Endone 5mg (oxycodone) (20 tablets pack) - 4820 tablets. 3. Between 1 January 2017 and 3 September 2018, the practitioner was one of two pharmacists in charge at the Pharmacy, during which time proper records of drugs of addiction were not maintained in the dangerous drugs register contrary to Clause 56 of the PTGR, including as follows: a) There was no record for Biodone liquid where there was a small amount stored at the Pharmacy (approximately 10mIs); b) The stock balance of Kalma 250mcg tablets was incorrect, showing 210 tablets when the actual balance was 220 tablets; c) The stock balance of Norspan 40mcg patches was incorrect, showing nil patches when the actual balance was 2 patches; d) The stock balance of Oxynorm 10mg capsules was incorrect, showing 40 capsules when the actual balance was 20 capsules; e) The stock balance of Targin 5mg/2.5mg tablets was incorrect, showing 196 tablets when the actual balance was 152 tablets; f) The stock balance of Suboxone 8mg films was incorrect, showing 349 films when the actual balance was 105 films; and g) The stock balance of Subutex 8mg tablets was incorrect, showing 126 tablets when the actual balance was 98 tablets. 4. On or about 15 July 2017, the practitioner's conduct whilst working at the Pharmacy led to the loss of 400 tablets of Endone 5mg (oxycodone), a drug of addiction. 5. The practitioner failed to undertake accurate stock checks as required by Clause 118 of the PTGR for drugs of addiction at the Pharmacy as follows: a) in March 2017; b) in September 2017; c) in March 2018; and d) in September 2018. 6. On 24 August 2018, the practitioner, took medications from the Pharmacy's dispensary and left the Pharmacy, without making payment for the medications. 7. Between March 2013 and 3 September 2018, the practitioner complied with the instructions of the other pharmacist in charge John Negus ("Mr Negus") at the Pharmacy to facilitate an exchange of the prescribed restricted substance Saxenda between two customers at the Pharmacy. 8. On or about 4 July 2015, the practitioner complied with the request of Mr Negus at the Pharmacy to supply an out of date prescribed restricted substance Alphamox Suspension to Mr Negus's cat without a valid prescription. 9. Between March 2013 and 3 September 2018, the practitioner supplied the prescribed restricted substances Valium and antibiotics to friends and family members of the pharmacist Niels Bowen (owner of Bowen Health Services) ("Mr Bowen") without valid prescriptions. 10. Between 1 January 2017 and 3 September 2018, the practitioner supplied prescribed restricted substances to customers and family members on the instructions of Mr Negus without valid prescriptions. 11. Between 1 January 2017 and 3 September 2018, the practitioner inappropriately left her password to the electronic dangerous drugs register on a post it note near the dispensary computer keyboard. 12. Prior to 3 September 2018, the practitioner whilst working at the Pharmacy did not take any appropriate action after finding blank prescription pads in the Pharmacy. 13. Prior to 3 September 2018, the practitioner, whilst working at the Pharmacy, witnessed Mr Bowen take a prescribed restricted substance Temaze without a valid prescription and without the medication being dispensed at the Pharmacy and did not take any action. COMPLAINT TWO is guilty of unsatisfactory professional conduct under section 139B(1)(e) of the National Law in that the practitioner has: i. Contravened section 34A(4) of the Health Care Complaints Act 1993 (NSW) ("HCCA"). BACKGROUND TO COMPLAINT TWO On 31 July 2019, the Health Care Complaints Commission issued the practitioner a Notice to Appear before the Health Care Complaints Commission to give oral evidence under section 34A(1)(c) of the HCCA requiring the practitioner to attend the Health Care Complaints Commission's offices at 10:00am on Wednesday, 14 August 2019. On 31 July 2019, the practitioner emailed the Health Care Complaints Commission confirming receipt of the Notice to Appear. PARTICULARS OF COMPLAINT TWO 1. On 14 August 2019, the practitioner failed to comply with the Notice to Appear issued by the Health Care Complaints Commission under section 34A(1)(c) of the HCCA without a reasonable excuse in breach of section 34A(4) of the HCCA. COMPLAINT THREE is guilty of professional misconduct under section 139E of the National Law in that the practitioner has: i. engaged in unsatisfactory professional conduct of a sufficiently serious nature to justify suspension or cancellation of the practitioner's registration, or ii. engaged in more than one instance of unsatisfactory professional conduct that, when the instances are considered together, amount to conduct of a sufficiently serious nature to justify the suspension or cancellation of the practitioner's registration PARTICULARS OF COMPLAINT THREE 1. Complaints One and Two and the particulars thereof are repeated and relied upon both individually and cumulatively. COMPLAINT FOUR Pursuant to section 144(d) of the National Law the practitioner has an impairment within the meaning of section 5 of the National Law, being a mental impairment, disability, condition or disorder that detrimentally affects or is likely to detrimentally affect the practitioner's capacity to practice [sic] the profession. BACKGROUND TO COMPLAINT FOUR The practitioner was assessed by Consultant Psychiatrist Dr Robert Gertler on 18 February 2021. In a report prepared by Dr Gertler of 22 February 2021, Dr Gertler records that the practitioner has been diagnosed with Autism Spectrum Disorder (Asperger's Syndrome). That diagnosis is reported in letters dated 22 January 2020 and 10 September 2020, under the hand of Dr Leanne Laut. According to Dr Gertler, Ms Haydon has also suffered from major depression since 2012 for which she has been under intensive psychiatric and psychological treatment since 2018. PARTICULARS OF COMPLAINT FOUR The practitioner has been diagnosed as suffering from mental illness, namely: 1. Autism Spectrum Disorder (Asperger's Syndrome); and 2. Major Depression COMPLAINT FIVE Pursuant to section 139(a) of the National Law, the practitioner is not competent in that she lacks the mental capacity to practise as a pharmacist. BACKGROUND TO COMPLAINT FIVE The background set out under Complaint Four is relied upon. PARTICULARS OF COMPLAINT FIVE 1. Complaint Four and the particulars thereof are relied upon. 2. The practitioner's impairment is of a sufficient nature and degree that it detrimentally affects or is likely to detrimentally affect the practitioner's mental capacity to practise the profession.